loading
Schlusskurs vom Vortag:
$2.86
Offen:
$2.82
24-Stunden-Volumen:
2.65M
Relative Volume:
1.06
Marktkapitalisierung:
$487.78M
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-1.0161
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
+1.97%
1M Leistung:
-2.90%
6M Leistung:
-40.11%
1J Leistung:
-62.22%
1-Tages-Spanne:
Value
$2.80
$2.99
1-Wochen-Bereich:
Value
$2.75
$3.16
52-Wochen-Spanne:
Value
$1.775
$10.72

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Firmenname
Relay Therapeutics Inc
Name
Telefon
617-370-8837
Name
Adresse
399 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
259
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-21
Name
Neueste SEC-Einreichungen
Name
RLAY's Discussions on Twitter

Vergleichen Sie RLAY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RLAY
Relay Therapeutics Inc
2.845 478.33M 25.55M -341.97M -304.44M -2.80
Biotechnology icon
ONC
Beigene Ltd Adr
238.76 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
434.03 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.2548 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
596.85 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
72.69 5.92B 0 -153.72M -103.81M -2.00

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-17 Eingeleitet Wells Fargo Equal Weight
2024-09-10 Fortgesetzt Goldman Buy
2024-09-10 Hochstufung Jefferies Hold → Buy
2024-09-10 Herabstufung Oppenheimer Outperform → Perform
2024-05-10 Hochstufung Barclays Equal Weight → Overweight
2023-04-20 Hochstufung Jefferies Underperform → Hold
2023-04-19 Hochstufung Raymond James Outperform → Strong Buy
2023-04-13 Eingeleitet Raymond James Outperform
2023-02-03 Eingeleitet Oppenheimer Outperform
2022-09-30 Eingeleitet Barclays Equal Weight
2022-09-02 Eingeleitet Stifel Buy
2022-06-06 Eingeleitet Jefferies Underperform
2022-02-01 Eingeleitet Berenberg Buy
2021-07-21 Eingeleitet BofA Securities Buy
2020-12-15 Bestätigt H.C. Wainwright Buy
2020-12-08 Eingeleitet JMP Securities Mkt Outperform
2020-11-05 Eingeleitet H.C. Wainwright Buy
2020-08-10 Eingeleitet Cowen Outperform
2020-08-10 Eingeleitet Goldman Buy
2020-08-10 Eingeleitet Guggenheim Buy
2020-08-10 Eingeleitet JP Morgan Neutral
Alle ansehen

Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten

pulisher
May 22, 2025

Northern Trust Corp Buys 231,713 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 22, 2025
pulisher
May 21, 2025

BNP Paribas Financial Markets Invests $987,000 in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 21, 2025
pulisher
May 17, 2025

Stifel Financial Corp Makes New Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 17, 2025
pulisher
May 16, 2025

Layoff Tracker: Allogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs - BioSpace

May 16, 2025
pulisher
May 16, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

May 16, 2025
pulisher
May 14, 2025

Transcript : Relay Therapeutics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Relay Therapeutics, Inc. (RLAY): One of the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance

May 13, 2025
pulisher
May 12, 2025

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Issues Optimistic Forecast for RLAY Earnings - Defense World

May 12, 2025
pulisher
May 11, 2025

Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - MSN

May 11, 2025
pulisher
May 11, 2025

89,949 Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) Purchased by First Trust Advisors LP - Defense World

May 11, 2025
pulisher
May 10, 2025

Dimensional Fund Advisors LP Grows Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 10, 2025
pulisher
May 09, 2025

Q2 EPS Estimate for Relay Therapeutics Lowered by Analyst - Defense World

May 09, 2025
pulisher
May 08, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Hsbc Holdings PLC Has $458,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - The AM Reporter

May 08, 2025
pulisher
May 08, 2025

MetLife Investment Management LLC Grows Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 08, 2025
pulisher
May 07, 2025

Guggenheim Lowers Price Target for Relay Therapeutics (RLAY) to $10.00 | RLAY Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Relay Therapeutics (RLAY) Stock Target Reduced Amid Strategic Changes and Progress | RLAY Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Marshall Wace LLP Lowers Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 07, 2025

Raymond James Financial Inc. Takes $779,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 07, 2025

Wells Fargo & Company MN Decreases Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 06, 2025

Relay Therapeutics Inc (RLAY) Q1 2025 Earnings: EPS Loss of $0.4 - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Relay Therapeutics (RLAY) Reports Decline in Q1 Revenue | RLAY S - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Relay Therapeutics Extends Cash Runway and Advances Clinical Trials - TipRanks

May 06, 2025
pulisher
May 05, 2025

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates | RLAY Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics, Inc. SEC 10-Q Report - TradingView

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Extends Cash Runway into 2029 Amid Clinical Trial Advancements - Nasdaq

May 05, 2025
pulisher
May 05, 2025

Barclays PLC Has $1.29 Million Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 05, 2025
pulisher
May 04, 2025

Invesco Ltd. Acquires 5,261 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 04, 2025
pulisher
May 02, 2025

There Is A Lot Of Upside Potential For Relay Therapeutics Inc(NASDAQ: RLAY) - Stocksregister

May 02, 2025
pulisher
May 01, 2025

why Relay Therapeutics Inc [RLAY] is a Good Choice for Investors After New Price Target of $17.40 - dbtnews.com

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics executive sells $36,540 in stock By Investing.com - Investing.com Nigeria

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics executive sells $36,540 in stock - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

LPL Financial LLC Sells 6,564 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics president sells $95,381 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics chief legal officer sells $44,040 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics CFO sells shares worth $44,246 By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
Apr 30, 2025

Relay Therapeutics Inc Stock: Executives Sell Shares Amid Mixed Signals - sharewise

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics president sells $95,381 in stock - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics CFO sells shares worth $44,246 - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics chief legal officer sells $44,040 in stock - Investing.com

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics Executives Sell Shares to Cover Tax Obligations and Under Trading Plan - TradingView

Apr 30, 2025
pulisher
Apr 30, 2025

Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Trading Day Review: Relay Therapeutics Inc (RLAY) Loses Momentum, Closing at 3.10 - DWinneX

Apr 30, 2025

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$581.44
price down icon 0.60%
$1.39
price up icon 6.92%
$32.50
price down icon 0.28%
$289.00
price down icon 1.22%
$4.2299
price up icon 5.48%
$72.69
price down icon 1.89%
Kapitalisierung:     |  Volumen (24h):